Scott Platshon - Profile and Investment Details

Investor Profile

Scott Platshon is a Venture Capital, Private Equity Firm based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Ashvattha Therapeutics, Inc., Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals, Peloton Therapeutics, Ajax Therapeutics, Ardelyx, BridgeBio Oncology Therapeutics, Atara Biotherapeutics, Nabriva Therapeutics, Silverback Therapeutics, Metacrine, Kumquat Biosciences Inc., Prevail Therapeutics, Nuvation Bio, Editas Medicine, Relay Therapeutics, Aktis Oncology, Freenome, Scorpion Therapeutics, Avidity Biosciences, Alpine Immune Sciences, Naurex, Dicerna Pharmaceuticals, Flex Pharma, Morphic Therapeutic, ElevateBio, Surface Oncology, PellePharm, Collegium PharmaceuticalAffinivax, Codiak Biosciences, Neogene Therapeutics, UNITY Biotechnology, Intellia Therapeutics, Ashvattha Therapeutics, Pieris Pharmaceuticals, Atreca, AlloVir, Janux Therapeutics, ORIC Pharmaceuticals, Scholar Rock, Dewpoint Therapeutics, Clementia Pharmaceuticals, Accent Therapeutics, Solid Biosciences, Centessa Pharmaceuticals, Kronos Bio, Chinook Therapeutics, Artiva Biotherapeutics, Akouos, Gritstone Oncology, EcoR1 Capital, LLC, aTyr Pharma, Kura Oncology, Kezar Life Sciences, Arcus Biosciences, Nurix Therapeutics, Syndax Pharmaceuticals, Cellares, Terremoto Biosciences, Shattuck Labs, Neurogene, SAGE Therapeutics, . Over time, Scott Platshon has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Scott Platshon is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Autoimmune Diseases, Wellness, Investment Management, Android, Life Science, Software, Biotechnology, Productivity Software, Research, Health Diagnostics, Developer Tools, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Scott Platshon, as their portfolio suggests a familiarity and interest in this area.

Understanding Scott Platshon’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.